Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:species
|
| gptkbp:belongs_to |
genus Plasmodium
|
| gptkbp:cause |
malaria
|
| gptkbp:community_health |
WHO initiatives
malaria elimination strategies global malaria eradication efforts |
| gptkbp:controls |
case management
surveillance vector control |
| gptkbp:diagnosis |
blood smear
rapid diagnostic tests |
| gptkbp:discovered_by |
gptkb:Sir_Ronald_Ross
|
| gptkbp:duration |
3 days
|
| gptkbp:epidemiology |
seasonal outbreaks
endemic in some regions asymptomatic carriers |
| gptkbp:first_described_by |
1880
|
| gptkbp:geographic_distribution |
tropical regions
|
| gptkbp:has_features |
trophozoite stage
gametocyte stage ring stage schizont stage |
| gptkbp:hosts |
gptkb:humans
mosquitoes |
| https://www.w3.org/2000/01/rdf-schema#label |
Plasmodium malariae
|
| gptkbp:impact |
morbidity and mortality
economic burden public health issue |
| gptkbp:is_a |
species of Plasmodium
|
| gptkbp:is_vulnerable_to |
ongoing studies
no effective vaccine available |
| gptkbp:life_cycle |
complex life cycle
|
| gptkbp:prevention |
insecticide-treated nets
antimalarial prophylaxis indoor spraying |
| gptkbp:related_to |
gptkb:Plasmodium_falciparum
gptkb:Plasmodium_vivax gptkb:Plasmodium_ovale |
| gptkbp:research |
studied for vaccine development
|
| gptkbp:seed_dispersal |
~23 million base pairs
|
| gptkbp:symptoms |
headache
muscle pain nausea fever vomiting 1-2 weeks chills sweats |
| gptkbp:transmission |
mosquito bites
|
| gptkbp:treatment |
gptkb:chloroquine
gptkb:primaquine antimalarial drugs |
| gptkbp:treatment_resistance |
emerging resistance
|
| gptkbp:vector |
gptkb:Anopheles_mosquitoes
|
| gptkbp:bfsParent |
gptkb:Plasmodium
|
| gptkbp:bfsLayer |
7
|